Follow
Zlatan Mujagic
Zlatan Mujagic
M.D., Ph.D., Division of Gastroenterology and Hepatology, Maastricht University Medical Center
Verified email at maastrichtuniversity.nl
Title
Cited by
Cited by
Year
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
A Zhernakova, A Kurilshikov, MJ Bonder, EF Tigchelaar, M Schirmer, ...
Science 352 (6285), 565-569, 2016
17032016
Proton pump inhibitors affect the gut microbiome
F Imhann, MJ Bonder, AV Vila, J Fu, Z Mujagic, L Vork, EF Tigchelaar, ...
Gut 65 (5), 740-748, 2016
11192016
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
S Sanna, NR van Zuydam, A Mahajan, A Kurilshikov, A Vich Vila, U Vősa, ...
Nature genetics 51 (4), 600-605, 2019
9862019
Large-scale association analyses identify host factors influencing human gut microbiome composition
A Kurilshikov, C Medina-Gomez, R Bacigalupe, D Radjabzadeh, J Wang, ...
Nature genetics 53 (2), 156-165, 2021
7982021
The effect of host genetics on the gut microbiome
MJ Bonder, A Kurilshikov, EF Tigchelaar, Z Mujagic, F Imhann, AV Vila, ...
Nature genetics 48 (11), 1407-1412, 2016
7482016
Impact of commonly used drugs on the composition and metabolic function of the gut microbiota
A Vich Vila, V Collij, S Sanna, T Sinha, F Imhann, AR Bourgonje, ...
Nature communications 11 (1), 362, 2020
5122020
Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome
A Vich Vila, F Imhann, V Collij, SA Jankipersadsing, T Gurry, Z Mujagic, ...
Science translational medicine 10 (472), eaap8914, 2018
4422018
Cohort profile: LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics
EF Tigchelaar, A Zhernakova, JAM Dekens, G Hermes, A Baranska, ...
BMJ open 5 (8), e006772, 2015
2622015
Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to …
Z Mujagic, S Ludidi, D Keszthelyi, MAM Hesselink, JW Kruimel, ...
Alimentary pharmacology & therapeutics 40 (3), 288-297, 2014
1222014
Rome III vs Rome IV criteria for irritable bowel syndrome: a comparison of clinical characteristics in a large cohort study
L Vork, ZZRM Weerts, Z Mujagic, JW Kruimel, MAM Hesselink, JWM Muris, ...
Neurogastroenterology & Motility 30 (2), e13189, 2018
1012018
The effects of Lactobacillus plantarum on small intestinal barrier function and mucosal gene transcription; a randomized double-blind placebo controlled trial
Z Mujagic, P De Vos, MV Boekschoten, C Govers, HJHM Pieters, ...
Scientific reports 7 (1), 40128, 2017
932017
Joosten LAB, Netea MG, Franke L, Zhernakova A, Fu J, Wijmenga C, McCarthy MI. 2019. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
S Sanna, NR van Zuydam, A Mahajan, A Kurilshikov, A Vich Vila, U Vősa, ...
Nat Genet 51 (4), 600-605, 0
76
Alterations in serotonin metabolism in the irritable bowel syndrome
AY Thijssen, Z Mujagic, D Jonkers, S Ludidi, D Keszthelyi, MA Hesselink, ...
Alimentary Pharmacology & Therapeutics 43 (2), 272-282, 2016
702016
Volatile organic compounds in exhaled air as novel marker for disease activity in Crohn's disease: a metabolomic approach
AGL Bodelier, A Smolinska, A Baranska, JW Dallinga, Z Mujagic, ...
Inflammatory bowel diseases 21 (8), 1776-1785, 2015
672015
Markers for visceral hypersensitivity in patients with irritable bowel syndrome
S Ludidi, Z Mujagic, D Jonkers, D Keszthelyi, M Hesselink, J Kruimel, ...
Neurogastroenterology & Motility 26 (8), 1104-1111, 2014
642014
Intestinal barrier function is maintained with aging–a comprehensive study in healthy subjects and irritable bowel syndrome patients
E Wilms, FJ Troost, M Elizalde, B Winkens, P de Vos, Z Mujagic, ...
Scientific Reports 10 (1), 475, 2020
572020
Systematic review: instruments to assess abdominal pain in irritable bowel syndrome
Z Mujagic, D Keszthelyi, Q Aziz, W Reinisch, EG Quetglas, ...
Alimentary pharmacology & therapeutics 42 (9), 1064-1081, 2015
572015
The Experience Sampling Method‐a new digital tool for momentary symptom assessment in IBS: an exploratory study
Z Mujagic, C Leue, L Vork, R Lousberg, DMAE Jonkers, D Keszthelyi, ...
Neurogastroenterology & Motility 27 (9), 1295-1302, 2015
562015
A novel biomarker panel for irritable bowel syndrome and the application in the general population
Z Mujagic, EF Tigchelaar, A Zhernakova, T Ludwig, J Ramiro-Garcia, ...
Scientific reports 6 (1), 26420, 2016
532016
The enteric nervous system relays psychological stress to intestinal inflammation
KM Schneider, N Blank, Y Alvarez, K Thum, P Lundgren, L Litichevskiy, ...
Cell 186 (13), 2823-2838. e20, 2023
502023
The system can't perform the operation now. Try again later.
Articles 1–20